Three receptors
GLP-1, GIP, and glucagon are the three targets. The “3” nickname is not the molecule’s scientific name.
PEPTIDE CURIOUS? COME SIT WITH US.
← Back to The Glow Guide01 02 03 Three good questions
THE GLOW GUIDE / RESEARCH PROFILE 08
GLP-3?
The nickname points to retatrutide.
One molecule, three receptor targets, and a lot of conversation. Here’s what the name means, what has been studied in people, and why the exact product matters.
REAL-LIFE RESEARCH NOTES / DES MOINES
My research, in real life.
I track what I personally use and notice in everyday life. I can share my firsthand notes about retatrutide, while keeping one person’s experience separate from trial results and FDA review.
ON RETATRUTIDE / ASK ABOUT MY NOTES
Ask what I tracked and noticed, and what my experience cannot answer. I won’t turn a personal observation into a promise for someone else.
Ask about my retatrutide notes Start your message with “GLP-3” or “retatrutide.”01 / FOLLOW THE QUESTION
Start with the name.
Open the question you came with. Each answer links to the source behind it.
You may see “GLP-3” on peptide listings. The compound usually meant is retatrutide. Lilly calls it a triple receptor agonist: one molecule acting at GLP-1, GIP, and glucagon receptors. “GLP-3” is a seller shorthand, not its scientific name or an FDA-approved drug category.
02 / THE RESEARCH LENS
Three things to keep straight.
A studied drug
Human trial findings belong to retatrutide as studied, in the people and conditions in those trials.
An online vial
A familiar label does not establish identity, quality, sterility, or FDA approval.
03 / BEFORE YOU BELIEVE A CLAIM
Three good questions
to ask next.
- Does “GLP-3” here actually mean retatrutide?
- Is the claim from a human trial, or from a seller’s product page?
- What does FDA say about the exact product and its availability?
For decisions about your own health, talk with a licensed clinician who knows your history.
THE RECEIPTS
Go to the source.
Study findings and approval status can change. These are starting points for the exact molecule, trial, and current FDA concerns.
CURIOSITY, ENCOURAGED.
Still wondering
about retatrutide?
Tell us what you’ve heard and what you want to understand.
Message Glow Theory with questions Educational conversation only. No medical advice or treatment guidance.